1575596-29-0 (PRN1008,Rilzabrutinib)

PRN1008;Rilzabrutinib;5G1WE425BI;(R,E)-2-(3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile;Rilzabrutinib [INN];Rilzabrutinib [USAN];Rilzabrutinib, (E)-;Rilzabrutinib (USAN/INN);GTPL9993;BDBM143212;PRN 1008;WHO 10966;PRN1008, (E)-;Example 31 [WO2014039899];D11873;US89;

MFCD31631583

LCFFREMLXLZNHE-GBOLQPHISA-N

1S/C36H40FN9O3/c1-36(2,45-15-13-43(14-16-45)26-21-48-22-26)18-24(19-38)35(47)44-12-6-7-25(20-44)46-34-31(33(39)40-23-41-34)32(42-46)29-11-10-28(17-30(29)37)49-27-8-4-3-5-9-27/h3-5,8-11,17-18,23,25-26H,6-7,12-16,20-22H2,1-2H3,(H2,39,40,41)/b24-18+/t25-/m1/s1

FC1C([H])=C(C([H])=C([H])C=1C1C2=C(N([H])[H])N=C([H])N=C2N([C@]2([H])C([H])([H])C([H])([H])C([H])([H])N(C(/C(/C#N)=C(\[H])/C(C([H])([H])[H])(C([H])([H])[H])N3C([H])([H])C([H])([H])N(C([H])([H])C3([H])[H])C3([H])C([H])([H])OC3([H])[H])=O)C2([H])[H])N=1)OC1C([H])=C([H])C([H])=C([H])C=1[H]